RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020
- DOI
- 10.1080/21645515.2022.2140533
- Published
- 2022-11-22
- Container
- Human Vaccines & Immunotherapeutics
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/21645515.2022.2140533,
title = {RSV-related hospitalization and outpatient palivizumab use in very preterm (born at \<29 wGA) infants: 2003-2020},
author = {Elizabeth R. Packnett and Isabelle H. Winer and Heather Larkin and Abiola Oladapo and Tara Gonzales and Matthew Wojdyla and Mitchell Goldstein and Vincent C. Smith},
year = {2022},
journal = {Human Vaccines \& Immunotherapeutics},
doi = {10.1080/21645515.2022.2140533},
url = {https://doi.org/10.1080/21645515.2022.2140533}
}RIS
TY - JOUR TI - RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020 AU - Elizabeth R. Packnett AU - Isabelle H. Winer AU - Heather Larkin AU - Abiola Oladapo AU - Tara Gonzales AU - Matthew Wojdyla AU - Mitchell Goldstein AU - Vincent C. Smith PY - 2022 JO - Human Vaccines & Immunotherapeutics DO - 10.1080/21645515.2022.2140533 UR - https://doi.org/10.1080/21645515.2022.2140533 ER -
APA
Packnett, E. R., Winer, I. H., Larkin, H., Oladapo, A., Gonzales, T., Wojdyla, M., Goldstein, M., & Smith, V. C. (2022). RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2022.2140533
Source records
- crossref · retrieved 2026-09-26T04:47:41.604Z